A Double Blind Study of the Effect of Tranexamic Acid in Essential Menorrhagia

Summary

Oral administration of tranexamic acid, in a dosage of 3 g daily from the first day of menstruation onwards, significantly decreases menstrual haemoglobin loss in women with so-called essential menorrhagia.

The frequency of side-effects reported did not differ between “active” and “placebo” periods.

• References

• 1 Dubber A.H.C, McNicol G.P, Douglas A.S, Melander B. Some properties of the antifibrino-lytic active isomer of aminomethyl cyclohexane carboxylic acid. Lancet 1964; II: 1317
• 2 Hallberg L, Högdahl A.M, Nilsson L, Rybo G. Menstrual blood losses in a population sample. Acta obstet. gynec. scand 1964; 43: 7 Suppl
• 3 Hallberg L, Nilsson L. Determination of menstrual blood loss. Scandinav. J. clin. Lab. Invest 1964; 16: 244
• 4 Nilsson I.M, Björkman S.E. Experience with E-Aminocaproic acid (E-ACA) in the treatment of profuse menstruation. Acta med. scand 1965; 175: 445
• 5 Nilsson L, Rybo G. Treatment of menorrhagia with epsilon aminocaproic acid. A double blind investigation. Acta Obstet gynec. scand 1965; 44: 467
• 6 Rustad H. Measurement of blood-loss during surgery. Lancet 1963; I: 1304
• 7 Rybo G. Plasminogen activators in the endometrium. I. Methodological aspects. Acta Obstet gynec. scand 1966; 45: 411
• 8 Rybo G. Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss. Acta Obstet. gynec. scand 1966; 45: 429